Position in VKTX
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$318,711
+$22,467 QoQ
Shares Held
8,170
-10.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#4
of 10 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Derivatives in VKTX
reported options exposure · as of Jun 30, 2026CallValue
$6,397
CallShares
164
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026FNY Investment Advisers, LLC holds $19,945,542 across 57 Biotechnology names. VKTX ranks #8 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NUVL |
Nuvalent, Inc.
|
108,951 | $13,455,448 | |
| 2 | ABVX |
Abivax S.A.
|
7,605 | $1,013,442 | |
| 3 | SGMT |
Sagimet Biosciences Inc.
|
109,250 | $844,502 | |
| 4 | APGE |
Apogee Therapeutics, Inc.
|
5,000 | $663,650 | |
| 5 | JANX |
Janux Therapeutics, Inc.
|
30,850 | $473,856 | |
| 6 | NKTR |
Nektar Therapeutics
|
5,500 | $383,955 | |
| 7 | VERU |
Veru Inc.
|
105,081 | $328,903 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
This page
|
8,170 | $318,711 |
All Filings in VKTX
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $318,711 | 8,170 | Shares | Defined | 2026-07-08 | |
| 2026-06-30 | $6,397 | 164 | Call | Defined | 2026-07-08 | |
| 2026-03-31 | $2,017 | 62 | Call | Defined | 2026-04-15 | |
| 2026-03-31 | $296,244 | 9,104 | Shares | Defined | 2026-04-15 | |
| 2025-12-31 | $1,442 | 41 | Call | Defined | 2026-01-16 | |
| 2025-12-31 | $368,123 | 10,464 | Shares | Defined | 2026-01-16 | |
| 2025-09-30 | $305,583 | 11,628 | Shares | Defined | 2025-12-15 | |
| 2025-06-30 | $208,926 | 7,884 | Shares | Defined | 2025-07-30 | |
| 2025-06-30 | $2,862 | 108 | Call | Defined | 2025-07-30 | |
| 2025-03-31 | $483 | 20 | Call | Sole | 2025-04-17 | |
| 2025-03-31 | $146,107 | 6,050 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $1,408 | 35 | Call | Sole | 2025-01-13 | |
| 2024-12-31 | $247,476 | 6,150 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $758,137 | 11,975 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $15,849 | 299 | Call | Sole | 2024-08-05 | |
| 2024-06-30 | $351,827 | 6,637 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $11,562 | 141 | Call | Sole | 2024-05-03 | |
| 2024-03-31 | $430,500 | 5,250 | Shares | Sole | 2024-05-03 | |
| 2022-12-31 | $376 | 40 | Shares | Sole | 2023-01-10 | |
| 2022-09-30 | $489 | 180 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $520 | 180 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $540 | 180 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $828 | 180 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $1,130 | 180 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $1,078 | 180 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $1,138 | 180 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $1,238 | 220 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $1,280 | 220 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $1,586 | 220 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $1,029 | 220 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||